Breaking News, Collaborations & Alliances

CMAB and Kintor Enter Mfg. Tie-up

Collaboration aims to develop and manufacture the ALK-1 monoclonal antibody

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CMAB Biopharma (Suzhou) Inc., a pure-play CDMO business in biologics, and Suzhou Kintor Pharmaceuticals, Inc., an innovative biopharmaceutical enterprise, have formed a strategic cooperation agreement for the development and manufacturing of Kintor’s ALK-1 mAb.   ALK-1 mAb has been studied in two Phase-I clinical trials in the U.S., Italy, South Korea and Japan from 2007 to 2014. In these two clinical studies, ALK-1 mAb demonstrated favorable PK and safety profile and reasonable clinical b...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters